Sarah Cannon, Our Cancer Institute
As a global leader in cancer research and care, Sarah Cannon, the Cancer Institute of HCA Healthcare, serves hundreds of thousands of patients annually across the United States and United Kingdom. Recognized for its expertise in drug development, Sarah Cannon has conducted more than 300 first-in-human trials and has been a clinical trial leader in the majority of approved cancer therapies over the last 10 years.
Sarah Cannon’s cancer programs include individualized patient navigation provided by oncology-trained nurses, more than 1,000 stem cell transplants performed annually throughout the Sarah Cannon Blood Cancer Network, hundreds of clinical trials accessed through its network of research sites, as well as molecular profiling capabilities and technology that ensure each patient receives the right therapy at the right time.
Nurse Navigation and Cutting-Edge Treatment
Sarah Cannon is one of the largest providers of surgical, medical and radiation oncology services. The Sarah Cannon Blood Cancer Network has earned recognition as an international leader in blood and marrow transplantation (BMT), and has conducted approximately 14,000 transplants since inception.
With the support of our nurse navigators working with patients from diagnosis through survivorship, Sarah Cannon’s navigation program ensures seamless communications and coordination for patients and their care teams, which has resulted in improved timeliness of care and patient experience.
Backing of a Major Healthcare System
By being a part of HCA Healthcare, oncologists are supported through an established network that places value on quality-based care with a deep focus on clinical pathways and improved outcomes. With 85% of patients treated in community setting, physicians have the ability to impact a larger population of people facing cancer on an international scale. Access to research, which includes the ability to accelerate drug development and clinical trials, utilize molecular profiling capabilities and decision support through the latest technology and data insights – provides physicians access to the resources they need to ensure the delivery of personalized care for each patient.
Sarah Cannon and its network of programs across HCA Healthcare also provide many career development opportunities as a physician leader. Whether it is in administration at an individual hospital, key disease programs workgroups, or participation in community-based clinical research and early-phase drug development, physicians have many options to expand their reach in the field of oncology.
Sarah Cannon’s network of oncologists oversee quality standards and program development to build centers of excellence for every major cancer type that are recognized by the top accrediting organizations in cancer.
Our accreditations include:
- 75 hospitals accredited by the Commission on Cancer, a program of the American College of Surgeons
- 35 sites accredited by National Accreditation Program for Breast Centers, a program of the American College of Surgeons
- 7 FACT-accredited programs (Foundation for the Accreditation of Cellular Therapy)
Our community-based care model makes cutting-edge cancer treatment accessible to more patients nationwide than any other healthcare system.
HCA also offers affiliated private practice oncology jobs in markets where Sarah Cannon is not currently operating. Please reach out for more info about these opportunities.
Interested in joining our growing team? We are seeking qualified, board certified (or if newly trained, board eligible) physicians.